Vulnerability of the medical product supply chain: the wake-up call of COVID-19

Fiona A Miller,Steven B Young,Mark Dobrow,Kaveh G Shojania
DOI: https://doi.org/10.1136/bmjqs-2020-012133
2020-11-02
Abstract:Introduction <p>The COVID-19 pandemic has brought the long-standing vulnerability of the medical product supply chain into sharp focus. Global shortages of medical products accompanied the global spread of the disease, joined by high prices, the proliferation of suspect dealers and dramatic interventions by governments, philanthropy and industry in oftentimes-unsuccessful attempts to secure solutions.</p> <p>Much attention has focused on personal protective equipment (PPE). But reported shortages have extended much further—to testing supplies, dialysis materials, pharmaceuticals and a wide range of commodities essential for daily care delivery—both for patients with and without COVID-19.1 2</p> <p>PPE shortages have received particular attention because they endanger the healthcare workforce.3 But <i>all</i> product shortages endanger patients due to delays in care, rationing or denial of care, the use of substandard products, or heightened risk of error when using replacement products—risks that extend to increased mortality.4 Medical...</p>
health care sciences & services,health policy & services
What problem does this paper attempt to address?